Alternative splicing of PDLIM3/ALP, for α-actinin-associated LIM protein 3, is aberrant in persons with myotonic dystrophy

Biochemical and Biophysical Research Communications

Volumn 409, Issue 1, 2011, Pages 64-69

  Ohsawa, Natsumi ^a   Koebis, Michinori ^a   Suo, Satoshi ^a   Nishino, Ichizo ^b   Ishiura, Shoichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Actinin associated LIM protein 3 (PDLIM3 ALP); Alternative splicing; MBNL; Myotonic dystrophy; Sarcoplasmic endoplasmic reticulum Ca ATPase 1 (SERCA1); ZASP like motif

Indexed keywords

ALPHA ACTININ; ALPHA ACTININ ASSOCIATED LIM PROTEIN 3; FIBRONECTIN; FIBRONECTIN 1; GENE PRODUCT; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; DMPK GENE; FN1 GENE; GENE; HUMAN; HUMAN TISSUE; MUSCLE WEAKNESS; MYOTONIC DYSTROPHY; NUCLEOTIDE SEQUENCE; PDLIM3 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RNA SPLICING; RNA TRANSCRIPTION;

ALTERNATIVE SPLICING; BRAIN; EXONS; FIBRONECTINS; HUMANS; LIVER; MICROFILAMENT PROTEINS; MUSCLE, SKELETAL; MYOTONIC DYSTROPHY;

EID: 79956209642     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.106     Document Type: Article

References (37)

1. Harper P. Myotonic Dystrophy 2001, W.B. Saunders, London. third ed.
2. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburatani H., Hunter K., Stanton V.P., Thirion J.P., Hudson T., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992, 69:385.
3. Fu Y.H., Friedman D.L., Richards S., Pearlman J.A., Gibbs R.A., Pizzuti A., Ashizawa T., Perryman M.B., Scarlato G., Fenwick R.G., et al. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 1993, 260:235-238.
4. Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G., Neville C., Narang M., Barcelo J., O'Hoy K., et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 1992, 255:1253-1255.
5. Liquori C.L., Ricker K., Moseley M.L., Jacobsen J.F., Kress W., Naylor S.L., Day J.W., Ranum L.P. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001, 293:864-867.
6. Mankodi A., Logigian E., Callahan L., McClain C., White R., Henderson D., Krym M., Thornton C.A. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000, 289:1769-1773.
7. Taneja K.L., McCurrach M., Schalling M., Housman D., Singer R.H. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 1995, 128:995-1002.
8. Kanadia R.N., Johnstone K.A., Mankodi A., Lungu C., Thornton C.A., Esson D., Timmers A.M., Hauswirth W.W., Swanson M.S. A muscleblind knockout model for myotonic dystrophy. Science 2003, 302:1978-1980.
9. Charlet B.N., Savkur R.S., Singh G., Philips A.V., Grice E.A., Cooper T.A. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 2002, 10:45-53.
10. Mankodi A., Takahashi M.P., Jiang H., Beck C.L., Bowers W.J., Moxley R.T., Cannon S.C., Thornton C.A. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 2002, 10:35-44.
11. Philips A.V., Timchenko L.T., Cooper T.A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998, 280:737-741.
12. Kimura T., Nakamori M., Lueck J.D., Pouliquin P., Aoike F., Fujimura H., Dirksen R.T., Takahashi M.P., Dulhunty A.F., Sakoda S. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. Hum. Mol. Genet. 2005, 14:2189-2200.
13. Savkur R.S., Philips A.V., Cooper T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 2001, 29:40-47.
14. Savkur R.S., Philips A.V., Cooper T.A., Dalton J.C., Moseley M.L., Ranum L.P., Day J.W. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am. J. Hum. Genet. 2004, 74:1309-1313.
15. Lin X., Miller J.W., Mankodi A., Kanadia R.N., Yuan Y., Moxley R.T., Swanson M.S., Thornton C.A. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet. 2006, 15:2087-2097.
16. Ranum L.P., Cooper T.A. RNA-mediated neuromuscular disorders. Annu. Rev. Neurosci. 2006, 29:259-277.
17. Kino Y., Washizu C., Oma Y., Onishi H., Nezu Y., Sasagawa N., Nukina N., Ishiura S. MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. Nucleic Acids Res. 2009, 37:6477-6490.
18. Ho T.H., Charlet B.N., Poulos M.G., Singh G., Swanson M.S., Cooper T.A. Muscleblind proteins regulate alternative splicing. EMBO J. 2004, 23:3103-3112.
19. Hino S., Kondo S., Sekiya H., Saito A., Kanemoto S., Murakami T., Chihara K., Aoki Y., Nakamori M., Takahashi M.P., Imaizumi K. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1. Hum. Mol. Genet. 2007, 16:2834-2843.
20. Dansithong W., Paul S., Comai L., Reddy S. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J. Biol. Chem. 2005, 280:5773-5780.
21. Xia H., Winokur S.T., Kuo W.L., Altherr M.R., Bredt D.S. Actinin-associated LIM protein: identification of a domain interaction between PDZ and spectrin-like repeat motifs. J. Cell Biol. 1997, 139:507-515.
22. Jo K., Rutten B., Bunn R.C., Bredt D.S. Actinin-associated LIM protein-deficient mice maintain normal development and structure of skeletal muscle. Mol. Cell. Biol. 2001, 21:1682-1687.
23. Frank D., Kuhn C., Katus H.A., Frey N. The sarcomeric Z-disc: a nodal point in signalling and disease. J. Mol. Med. 2006, 84:446-468.
24. Kanadia R.N., Shin J., Yuan Y., Beattie S.G., Wheeler T.M., Thornton C.A., Swanson M.S. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc. Natl. Acad. Sci. USA 2006, 103:11748-11753.
25. Brandl C.J., Green N.M., Korczak B., MacLennan D.H. Two Ca2+ ATPase genes: homologies and mechanistic implications of deduced amino acid sequences. Cell 1986, 44:597-607.
26. Brandl C.J., deLeon S., Martin D.R., MacLennan D.H. Adult forms of the Ca2+ATPase of sarcoplasmic reticulum. Expression in developing skeletal muscle. J. Biol. Chem. 1987, 262:3768-3774.
27. Kalsotra A., Xiao X., Ward A.J., Castle J.C., Johnson J.M., Burge C.B., Cooper T.A. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc. Natl. Acad. Sci. USA 2008, 105:20333-20338.
28. Klaavuniemi T., Kelloniemi A., Ylanne J. The ZASP-like motif in actinin-associated LIM protein is required for interaction with the alpha-actinin rod and for targeting to the muscle Z-line. J. Biol. Chem. 2004, 279:26402-26410.
29. Klaavuniemi T., Alho N., Hotulainen P., Kelloniemi A., Havukainen H., Permi P., Mattila S., Ylanne J. Characterization of the interaction between actinin-associated LIM protein (ALP) and the rod domain of alpha-actinin. BMC Cell Biol. 2009, 10:22.
30. Arola A.M., Sanchez X., Murphy R.T., Hasle E., Li H., Elliott P.M., McKenna W.J., Towbin J.A., Bowles N.E. Mutations in PDLIM3 and MYOZ1 encoding myocyte Z line proteins are infrequently found in idiopathic dilated cardiomyopathy. Mol. Genet. Metab. 2007, 90:435-440.
31. Bagnall R.D., Yeates L., Semsarian C. Analysis of the Z-disc genes PDLIM3 and MYPN in patients with hypertrophic cardiomyopathy. Int. J. Cardiol. 2010, 145:601-602.
32. Pashmforoush M., Pomies P., Peterson K.L., Kubalak S., Ross J., Hefti A., Aebi U., Beckerle M.C., Chien K.R. Adult mice deficient in actinin-associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy. Nat. Med. 2001, 7:591-597.
33. McKeown C.R., Han H.F., Beckerle M.C. Molecular characterization of the Caenorhabditis elegans ALP/enigma gene alp-1. Dev. Dyn. 2006, 235:530-538.
34. Zhou Q., Chu P.H., Huang C., Cheng C.F., Martone M.E., Knoll G., Shelton G.D., Evans S., Chen J. Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J. Cell Biol. 2001, 155:605-612.
35. Vatta M., Mohapatra B., Jimenez S., Sanchez X., Faulkner G., Perles Z., Sinagra G., Lin J.H., Vu T.M., Zhou Q., Bowles K.R., Di Lenarda A., Schimmenti L., Fox M., Chrisco M.A., Murphy R.T., McKenna W., Elliott P., Bowles N.E., Chen J., Valle G., Towbin J.A. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J. Am. Coll. Cardiol. 2003, 42:2014-2027.
36. Selcen D., Engel A.G. Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann. Neurol. 2005, 57:269-276.
37. Pomies P., Pashmforoush M., Vegezzi C., Chien K.R., Auffray C., Beckerle M.C. The cytoskeleton-associated PDZ-LIM protein, ALP, acts on serum response factor activity to regulate muscle differentiation. Mol. Biol. Cell 2007, 18:1723-1733.